A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. - Wikidata - awgldk - TriplyDB

A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.

A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.

http://www.wikidata.org/entity/Q37708089

about

Biomimetic and synthetic interfaces to tune immune responses Synthetic Nanoparticles for Vaccines and Immunotherapy Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases.Towards programming immune tolerance through geometric manipulation of phosphatidylserine.Targeted Delivery of Immunomodulators to Lymph Nodes.Reduction of T-Helper Cell Responses to Recall Antigen Mediated by Codelivery with Peptidoglycan via the Intestinal Nanomineral-Antigen Pathway.Development and Pre-Clinical Evaluation of Recombinant Human Myelin Basic Protein Nano Therapeutic Vaccine in Experimental Autoimmune Encephalomyelitis Mice Animal Model.Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds.Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).Engineering biomimetic materials for islet transplantation Mechanisms of immunological tolerance in central nervous system inflammatory demyelination.Harnessing nanoparticles for immune modulation Controlled release strategies for modulating immune responses to promote tissue regeneration Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation.Oligodendrocyte death results in immune-mediated CNS demyelination.Systemic Administration of Proteoglycan Protects BALB/c Retired Breeder Mice from Experimental Arthritis.Immune Tolerance for Autoimmune Disease and Cell Transplantation Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization.Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease.Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.Nanomaterial applications in multiple sclerosis inflamed brain.Guiding principles in the design of molecular bioconjugates for vaccine applications.Advancing drug delivery systems for the treatment of multiple sclerosis.Tolerogenic Nanoparticles to Treat Islet Autoimmunity.Tissue Engineering Approaches to Modulate the Inflammatory Milieu following Spinal Cord Injury.Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Engineering cell-based therapies to interface robustly with host physiology.Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.Cell membrane-derived nanomaterials for biomedical applications.In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.Nanomaterials in the Context of Type 2 Immune Responses-Fears and Potentials.Antigen-specific immunotherapies in rheumatic diseases.Nano- and micro-based systems for immunotolerance induction in multiple sclerosis.Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific Immunotherapy of Food Allergy: a Comprehensive Review.BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.Dendrimers: Breaking the paradigm of current musculoskeletal autoimmune therapies.

P2860

Q26801229-E8E70B45-C43E-4C1F-ACDA-4A17DC3FCEF8 Q28085375-532C0DEA-0E80-49C9-A9EE-7346BEAA8DFE Q30387307-D425164B-673E-4B29-87CA-E57BD42F588C Q30751004-4E428C1C-724D-4453-B14C-5EC4EA6195E3 Q30794718-51E78CD0-1912-44DE-B569-775294A0D4E6 Q30842126-4195D30A-31B5-48DD-95B7-B26E95A277D7 Q33582690-37175D24-096F-463E-B4A2-320A573EDD09 Q34018575-912BED54-EF32-496B-99BD-E661C02CF6B1 Q34506806-58FD2D47-ADAD-4BE7-A846-96CBF88046EA Q35498194-CE4822FF-3EB3-4CC6-A081-1C80A236384A Q35661081-F5979EFC-A471-4C87-BC92-A05BD85D6CCF Q36095922-ABB66819-B013-4EAE-A309-76FA5E31DD55 Q36154772-31C3AE8C-FAFB-454C-A744-C5735C3B76E5 Q36307642-4E62016D-4517-45EB-BD02-EC7E106D1A81 Q36327666-4B45B099-36EB-47F9-89D7-54FDFAD570F3 Q36816559-91FD2D5D-0141-4BB5-829B-F4B5ED29F0F5 Q36953054-203170B0-6DF1-4EF6-85B3-7A38F6609744 Q37099107-45F0901A-8635-4FA2-AC03-6AEDA5CD9ADB Q37173058-A6B54705-64A0-428D-823F-F926ABC43CA7 Q37174182-CD88CB23-7114-434F-B55D-3834B5B514FE Q37730171-4CCEFB56-78D5-47EF-9418-9FB4A31BA714 Q38297557-CFAB872F-214F-4F96-9486-79595E52094F Q38330408-2072A5EB-60E9-482A-99D3-D598876EDEA5 Q38395963-1085BD2F-7862-41C3-8A9D-936C0A2968AC Q38609620-28F996F1-B491-4F89-8723-82FDFA704810 Q38645059-3737A9C2-D43D-4A5D-9A33-379075448FFF Q38811130-E9C3C6B8-9D29-4B2C-86DD-AE81FF1327D9 Q38837294-1BA371C9-1D07-4440-B3E8-C0D30310AC27 Q38856242-88C4FED0-5DF4-4241-83DF-2C7C710031FC Q38896543-AA33D0FF-8668-480D-BB51-DD4048BF3EA3 Q39178313-83D71AE2-6CB8-420E-9655-E20A278DE2EF Q39245827-E64B7A96-ACA2-444B-9DE8-96606279C28D Q39294509-6A835391-27ED-4793-8F37-20822183540A Q39431371-9874287B-D349-4884-A412-CA6A811DFABA Q40786516-D4473831-F477-42AE-BF62-C9FB8582387C Q41101351-DB705723-B0D3-4F8B-838B-CF0A43806263 Q46222311-0E22CF92-DC4D-485B-BAA3-73783E2FC89D Q47105853-234C2693-58D8-429E-9F70-5B629C2BD6FF Q47234002-15272A65-9EFA-4FC9-8745-52D7342647C4 Q47429306-2286B346-8108-4EB3-B146-FA4CBB88E2AB

P2860

A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.

http://www.wikidata.org/entity/Q37708089

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A biodegradable nanoparticle p ...... eatment of autoimmune disease.

@en

A biodegradable nanoparticle p ...... eatment of autoimmune disease.

@nl

type

label

A biodegradable nanoparticle p ...... eatment of autoimmune disease.

@en

A biodegradable nanoparticle p ...... eatment of autoimmune disease.

@nl

prefLabel

A biodegradable nanoparticle p ...... eatment of autoimmune disease.

@en

A biodegradable nanoparticle p ...... eatment of autoimmune disease.

@nl

P1433

Q37708089-4280F641-8495-4066-B294-0BDFCEB50FFF

P1476

Q37708089-227BAD86-E581-44BA-A5E1-1514AAAB4D47

P2093

Q37708089-07E1BD5E-CB23-4703-949E-78FE11019D0B

Q37708089-3EE64A81-E3B2-48D5-97F4-FBD75D0BA5BC

Q37708089-43A0E21D-E40F-4E8A-BCED-69E948C863A2

Q37708089-9E0BB7C7-FA28-47AA-B57D-45E030CB3CCF

Q37708089-DAECA196-4898-44FC-B5FC-C5E4FB9C7CC6

Q37708089-E553A173-F9BC-4C7E-891E-081C3494E9D3

Q37708089-F9411F78-CE97-49C9-A827-8430056FCA83

P2860

Q37708089-074B6BE0-1D80-40FE-BC90-F792F988E8D1

Q37708089-0C86D221-731D-4A44-92F3-0E11A03D83DD

Q37708089-1485D962-7F12-4404-BDBF-BF143F046551

Q37708089-1AC66619-6865-431F-8C66-B1BD9180FC1F

Q37708089-28E39916-ED4C-4CE6-9819-7849D5486E7E

Q37708089-2C654369-06CC-4B2C-83BE-AD2816ADF52A

Q37708089-2F6EEF1F-DD14-4BE6-9AFE-47D7E9B2E656

Q37708089-2F7D7FA9-9C84-460C-BD4D-F1F6D9956905

Q37708089-30A36853-E90B-49E1-A618-033ED4D92EB3

Q37708089-391766B4-1135-40C6-8C4F-8F031F8CFC4A

P304

Q37708089-B245144B-B4F1-4308-A4EB-D325EF4E07FE

P31

Q37708089-34861620-EA01-4F36-9F18-74704DDA7B8A

P356

Q37708089-33C5D4E5-F3DD-4064-8F1F-DBF92BEB2991

P407

Q37708089-A26255A4-4715-4A1D-90B0-954C15543D11

P433

Q37708089-70CE4A92-D6C3-4CC7-BBC4-6590B1EC0D04

P478

Q37708089-89803E69-0024-449D-95D9-CAFE918BC064

P577

Q37708089-8B0710B3-F6AF-49D8-872D-5C6076521F1F

P5875

Q37708089-B4E104FA-9A6A-4140-86B8-E2A139A814DD

P698

Q37708089-C8D936CB-71E6-42B4-8FA4-04F8F3D8B4F4

P921

Q37708089-A861393D-CED9-4D35-AB1F-D81A73DF3EE0

Q37708089-BFD40470-050F-4C2F-ADAA-BD216B41D16E

P932

Q37708089-59AAF5FC-DE97-4986-B798-F7085E267BDA

P356

P1433

P1476

A biodegradable nanoparticle p ...... eatment of autoimmune disease.

@en

P2093

Christopher T Harp

http://www.w3.org/2001/XMLSchema#string

Daniel R Getts

http://www.w3.org/2001/XMLSchema#string

Derrick P McCarthy

http://www.w3.org/2001/XMLSchema#string

Lonnie D Shea

http://www.w3.org/2001/XMLSchema#string

Stephen D Miller

http://www.w3.org/2001/XMLSchema#string

Woon Teck Yap

http://www.w3.org/2001/XMLSchema#string

Zoe Hunter

http://www.w3.org/2001/XMLSchema#string

P2860

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

Therapeutic inflammatory monocyte modulation using immune-modifying microparticles

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

Immunological properties of engineered nanomaterials

Role of target geometry in phagocytosis.

Immunotherapy of type 1 diabetes: where are we and where should we be going?

Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis.

Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice

P304

2148-2160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NN405033R

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260373208

http://www.w3.org/2001/XMLSchema#string

P698

24559284

http://www.w3.org/2001/XMLSchema#string

P921

P932

3990004

http://www.w3.org/2001/XMLSchema#string